Literature DB >> 23304269

Data analysis: evaluation of nanoscale contrast agent enhanced CT scan to differentiate between benign and malignant lung cancer in mouse model.

Robert C Bell1, Deevakar Rogith, Craig W Johnson, Cristian T Badea, Khannan K Athreya, Gabriela Espinosa, Darin Clark, A Paiman Ghafoori, Yifan Li, David G Kirsch, Ananth Annapragada, Ketankumar Ghaghada.   

Abstract

Proposed is a method for statistical analysis for a small sample size, repeated measure experiment with nesting factors. In the original experiment the Student t-test was used for analysis. Using the same data, we modeled the experiment into two groups of mice with benign and malignant primary lung tumors. 4 tumor nodules were selected from each mouse (N= 36). The dependent variables are the volume, diameter, and signal attenuation measured using computed tomography (CT). The measurements are made before injecting the contrast and at 0, 72, and 168 hours after injection. The contrast agent enhances tumor nodule volume and volume differences between benign and malignant tumor nodules measured across time (p < 0.05). The signal attenuation measured across time differentiates between benign and malignant groups (p < 0.05). There is significant correlation between rate of change of volume and diameter of tumor. The advantages of this statistical method are discussed.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23304269      PMCID: PMC3540499     

Source DB:  PubMed          Journal:  AMIA Annu Symp Proc        ISSN: 1559-4076


  23 in total

1.  Pulmonary masses: contrast enhancement.

Authors:  J T Littleton; M L Durizch; G Moeller; D E Herbert
Journal:  Radiology       Date:  1990-12       Impact factor: 11.105

2.  Mouse model for lung tumorigenesis through Cre/lox controlled sporadic activation of the K-Ras oncogene.

Authors:  R Meuwissen; S C Linn; M van der Valk; W J Mooi; A Berns
Journal:  Oncogene       Date:  2001-10-04       Impact factor: 9.867

Review 3.  Tumour angiogenesis and its relation to contrast enhancement on computed tomography: a review.

Authors:  K A Miles
Journal:  Eur J Radiol       Date:  1999-06       Impact factor: 3.528

4.  Solitary pulmonary nodules: evaluation of blood flow patterns with dynamic CT.

Authors:  M Zhang; M Kono
Journal:  Radiology       Date:  1997-11       Impact factor: 11.105

5.  Lung nodule enhancement at CT: multicenter study.

Authors:  S J Swensen; R W Viggiano; D E Midthun; N L Müller; A Sherrick; K Yamashita; D P Naidich; E F Patz; T E Hartman; J R Muhm; A L Weaver
Journal:  Radiology       Date:  2000-01       Impact factor: 11.105

Review 6.  Diagnostic imaging of lung cancer.

Authors:  N Hollings; P Shaw
Journal:  Eur Respir J       Date:  2002-04       Impact factor: 16.671

7.  Variability in the detection of enlarged mediastinal lymph nodes in staging lung cancer: a comparison of contrast-enhanced and unenhanced CT.

Authors:  P N Cascade; B H Gross; E A Kazerooni; L E Quint; I R Francis; M Strawderman; M Korobkin
Journal:  AJR Am J Roentgenol       Date:  1998-04       Impact factor: 3.959

8.  Tumor doubling time and prognostic assessment of patients with primary lung cancer.

Authors:  K Usuda; Y Saito; M Sagawa; M Sato; K Kanma; S Takahashi; C Endo; Y Chen; A Sakurada; S Fujimura
Journal:  Cancer       Date:  1994-10-15       Impact factor: 6.860

Review 9.  Lung cancer screening with sputum cytologic examination, chest radiography, and computed tomography: an update for the U.S. Preventive Services Task Force.

Authors:  Linda L Humphrey; Steven Teutsch; Mark Johnson
Journal:  Ann Intern Med       Date:  2004-05-04       Impact factor: 25.391

10.  Computed tomography imaging of primary lung cancer in mice using a liposomal-iodinated contrast agent.

Authors:  Cristian T Badea; Khannan K Athreya; Gabriela Espinosa; Darin Clark; A Paiman Ghafoori; Yifan Li; David G Kirsch; G Allan Johnson; Ananth Annapragada; Ketan B Ghaghada
Journal:  PLoS One       Date:  2012-04-02       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.